<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN"
       "https://jats.nlm.nih.gov/publishing/1.3/JATS-journalpublishing1-3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" dtd-version="1.3" article-type="research-article" xml:lang="en">
 <front>
  <journal-meta>
   <journal-id journal-id-type="nlm-ta">Ulutas Med J</journal-id>
   <journal-title-group>
    <journal-title>The Ulutas Medical Journal</journal-title>
    <abbrev-journal-title>Ulutas Med J</abbrev-journal-title>
   </journal-title-group>
   <issn pub-type="ppub">2149-0430</issn>
   <issn pub-type="epub">2149-388X</issn>
   <publisher>
    <publisher-name>Hayriye Zehra Ulutaş</publisher-name>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="doi">10.5455/umj.20220118122431</article-id>
   <article-id pub-id-type="publisher-id">6598</article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>Original Article</subject>
    </subj-group>
    <subj-group subj-group-type="subject">
     <subject>Gastroenterology</subject>
    </subj-group>
   </article-categories>
   <title-group>
    <article-title>Retrospective Analysis of the Esophagogastroduodenoscopy Applications at Endoscopy Unit within Year 2017</article-title>
   </title-group>
   <contrib-group>
    <contrib contrib-type="author">
     <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9953-1714</contrib-id>
     <name name-style="western">
      <surname>Bulunmaz</surname>
      <given-names>Elif Boduc</given-names>
     </name>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
     <xref ref-type="aff" rid="aff1">1</xref>
    </contrib>
    <contrib contrib-type="author" corresp="yes">
     <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9532-8241</contrib-id>
     <name name-style="western">
      <surname>Gurler</surname>
      <given-names>Mujgan</given-names>
     </name>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
     <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
     <xref ref-type="aff" rid="aff2">2</xref>
    </contrib>
    <aff id="aff1">
     <label>1</label>
     <institution-wrap>
      <institution-id institution-id-type="ror">https://ror.org/01x1kqx83</institution-id>
      <institution>Bolu Abant Izzet Baysal University Faculty of Medicine, Department of Internal Medicine, Bolu, Turkey.</institution>
     </institution-wrap>
    </aff>
    <aff id="aff2">
     <label>2</label>
     <institution-wrap>
      <institution-id institution-id-type="ror">https://ror.org/01x1kqx83</institution-id>
      <institution>Bolu Abant Izzet Baysal University Faculty of Medicine, Department of Internal Medicine. Bolu, Turkey.</institution>
     </institution-wrap>
    </aff>
   </contrib-group>
   <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2022-03-09">
    <day>09</day>
    <month>03</month>
    <year>2022</year>
   </pub-date>
   <pub-date publication-format="print" date-type="collection">
    <year>2022</year>
   </pub-date>
   <volume>8</volume>
   <issue>1</issue>
   <fpage>18</fpage>
   <lpage>29</lpage>
   <history>
    <date date-type="received" iso-8601-date="2021-12-22">
     <day>22</day>
     <month>12</month>
     <year>2021</year>
    </date>
    <date date-type="rev-recd" iso-8601-date="2022-01-29">
     <day>29</day>
     <month>01</month>
     <year>2022</year>
    </date>
    <date date-type="accepted" iso-8601-date="2022-02-08">
     <day>08</day>
     <month>02</month>
     <year>2022</year>
    </date>
   </history>
   <permissions>
    <copyright-statement>© 2022 The Author(s)</copyright-statement>
    <copyright-year>2022</copyright-year>
    <license>
     <ali:license_ref>https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
     <license-p>This is an open access article distributed under the CC BY-NC 4.0 licence.</license-p>
    </license>
   </permissions>
   <self-uri xlink:href="https://www.ulutasmedicaljournal.com/?mno=6598"/>
   <self-uri content-type="pdf" xlink:href="https://www.ulutasmedicaljournal.com/pdf/6598.pdf"/>
   <abstract>
    <p>Introduction: The present study aimed to retrospectively evaluate the esophagogastroduodenoscopy (EGD) results of patients who applied to our hospital with gastrointestinal system (GIS) complaints. Materials and Methods: Five hundred patients who applied to our hospital's clinics with GIS complaints in 2017 were included in the study. EGD and biopsy findings performed in the endoscopy unit were analyzed retrospectively. Results: Sixty percent of the cases included in our study were female and 40% were male, and the mean age was 54.9±17.7 in females and 53.9±17.9 in males. Only 18 (3.6%) of 500 patients included in the study were found to be normal. The esophageal disease was present in 111 (22.2%) cases, the gastric disease was present in 474 (94.8%) and duodenal disease was present in 109 (21.8%) cases. In our study, gastritis was the most common disease among both gastric diseases and all patients who underwent endoscopy. Helicobacter pylori (HP) was seen in 165 (36.6%) of the cases. Conclusion: Upper GIS endoscopy means a very important procedure in terms of early diagnosis and treatment in patients presenting with various GIS complaints.</p>
   </abstract>
   <kwd-group kwd-group-type="author">
    <kwd>Duodenitis</kwd>
    <kwd>esophagogastroduodenoscopy</kwd>
    <kwd>gastritis</kwd>
    <kwd>Helicobacter pylori</kwd>
    <kwd>peptic ulcer</kwd>
   </kwd-group>
   <funding-group>
    <funding-statement>Conflict of Interest The authors declare that there is no conflict of interest and no financial support for the study.</funding-statement>
   </funding-group>
  </article-meta>
 </front>
 <body>
  <sec id="sec-1">
   <title>Introduction</title>
   <p id="b-1">Upper GIS endoscopy named esophagogastro duodenoscopy (EGD) includes visualization of the oropharynx, esophagus, stomach, proximal duodenum, real-time evaluation, interpretation of the obtained findings (    <xref ref-type="bibr" rid="ref1">1</xref>
). An EGD is indicated for the diagnostic evaluation of signs and symptoms of a wide variety of gastrointestinal disorders(    <xref ref-type="bibr" rid="ref2">2</xref>
). For diagnostic purpose; symptoms that include any of the following criteria; not responding to empirical therapy, associated with alarm symptoms, new-onset symptoms in a patient older than 50 years, dysphagia, odynophagia, persistent/recurrent esophageal reflux despite treatment, persistent vomiting of unknown cause, active or new upper GI bleeding and if any of the following are present, presumed chronic blood loss and iron deficiency anemia: there is clinical suspicion of an upper GI source, colonoscopy is negative and the lesion seen on upper GI tract imaging, acute caustic intake, when tissue or fluid is sampled on upper GIS tractus, in a patient with suspected small intestinal bowel disease (e.g. Celiac) and intraoperative evaluation of anatomical reconstructions. For scanning purposes; screening for dysplasia in patients with Barrett's esophagus, gastric cancer in selected patients, polyposis syndromes or upper GIS malignancies in patients with Lynch syndrome, esophageal varices in patients with portal hypertension, squamous cell carcinoma in patients with a history of caustic ingestion, to identify upper GIS pathology that may affect the treatment of other disorders (e.g. to evaluate a patient with a history of upper GI bleeding before initiation of anticoagulation). The key technical components of upper GIS endoscopy also serve as a platform on which many therapeutic interventions are based. For therapeutic purposes; bleeding treatment of upper GI tract lesions, prophylactic varicose banding, removal of foreign bodies, placement of feeding or drainage tubes, removal of selected polypoid lesions, dilatation of stenotic lesions, management of Achalasia, palliation of stenoses due to neoplasms, endoscopic treatment of intestinal metaplasia, treatment of operative complications (    <xref ref-type="bibr" rid="ref3">3</xref>
,    <xref ref-type="bibr" rid="ref4">4</xref>
).</p>
   <p id="b-2">With the prevalence of EGD, we encounter lesions of GIS more frequently and studies on this subject are very limited in our country. In this study, we retrospectively analyzed the endoscopic results of patients who applied to our outpatient clinic with GIS complaints.</p>
  </sec>
  <sec id="sec-2">
   <title>Materials and Methods</title>
  </sec>
  <sec id="sec-3">
   <title>Ethical Statement</title>
   <p id="b-3">The study complies with the provisions of the Declaration of Helsinki, which declares ethical principles to guide medical research. In addition, informed consent was obtained from all patients before the endoscopic procedure.</p>
  </sec>
  <sec id="sec-4">
   <title>Study Design</title>
   <p id="b-4">500 patients who applied to the clinics of our internal medicine and gastroenterology clinic of Abant İzzet Baysal University Medical Faculty Hospital in 2017 with GIS complaints were included in this study. Our study was designed as a cross-sectional retrospective study. EGD findings and biopsy results performed in the endoscopy unit of our hospital in 2017 were evaluated retrospectively. Patients under the age of 18 who were not admitted to our outpatient clinics due to their age and lower GIS endoscopy findings and biopsy results were not included in the study. The patients who applied to the clinics with GIS complaints were evaluated by anamnesis, physical examination, and then upper GIS endoscopic procedures included in this study.</p>
   <sec id="sec-5">
    <title>Statistical Evaluation</title>
    <p id="b-5">Kolmogorov Smirnov was used for normality. It was observed that our data were not normally distributed. Median, percentage, standard deviation, and frequency were used to express the data. Findings were summarized separately by frequency and percentage, age groups, and gender. In addition, the differences between gender and age groups were compared with Chi-square and Fisher's exact tests. SPSS 21.0 (SPSS Inc., Chicago, Illinois, USA) program was used for data analysis, statistical tests were interpreted at α=0.05 significance level. The level of p&lt;0.05 was accepted as significance.</p>
   </sec>
  </sec>
  <sec id="sec-6">
   <title>Results</title>
   <sec id="sec-7">
    <title>General Findings</title>
    <p id="b-6">Of the cases included in our study, 60% were female and 40% were male, with a mean age of 54.9±17.7 for females and 53.9±17.9 for males (Table-1). Of 500 patients included in the study, 18 (3.6%) were normal, the esophageal disease was found in 111 (22.2%) cases, while the gastric disease was 474 (94.8%) and duodenal disease was 109 (21.8%).</p>
   </sec>
   <sec id="sec-8">
    <title>Distribution of Lesions</title>
    <p id="b-7">There was no statistically significant difference in the distribution of lesions according to age (p=0.781)(Table-2). When the distribution of the lesions by gender was examined, the rate of endoscopic pathology in males and females differed statistically (p&lt;0.001). When the lesions were analyzed in detail according to their anatomical locations, it was observed that this was due to the high incidence of gastric lesions in females (p=0.001) (Table-3). In both genders, the most common lesion among esophageal lesions is esophagitis, and laxity of the lower esophageal sphincter (LES) is the second most common lesion (Table-1).</p>
    <table-wrap id="tbl-1" position="float">
     <label>Table 1</label>
     <caption>
      <title>Distribution of patients undergoing EGD</title>
     </caption>
     <graphic xlink:href="tbl-1.png">
      <alt-text>Table 1: Distribution of patients undergoing EGD</alt-text>
     </graphic>
    </table-wrap>
   </sec>
   <sec id="sec-9">
    <title>Features of Esophageal Lesions</title>
    <p id="b-8">In the distribution of esophageal lesions according to age groups; the incidence of hiatal hernia and esophageal varices is higher over the age of 50. (Hiatal hernia 0.6% vs 5.3% p=0.006; Esophageal varices 1.1% vs 5.3% p= 0.019) (Table-1). The endoscopic classification distribution of gastric lesions in males and females differs significantly (p=0.015).</p>
   </sec>
   <sec id="sec-10">
    <title>Features of Gastric Lesions</title>
    <p id="b-9">Considering the endoscopic topographic distribution of gastric lesions; pangastritis is the most common with 74.6%, and antral lesions are seen in the second line with 18.2%. Considering the gastritis type distribution of gastric lesions; superficial gastritis is the most common with 59%, followed by alkaline reflux gastritis with 19.4%. The distribution of other findings by gender does not differ (Table-6). In the endoscopic classification of gastric lesions and distribution by age group; there was a statistically significant difference in the gastritis category (p=0.047), but there was no significant difference in endoscopic topographic findings, ulcer, and malignancy incidence (p     <sub>=</sub>
0.364,      <sub>=</sub>
0.116, respectively) (Table-7).</p>
   </sec>
   <sec id="sec-11">
    <title>Histological Evaluation of Lesions</title>
    <p id="b-10">In the histological evaluation of gastric lesions by gender; considering the morphological distribution, inflammation was observed in all patients who underwent biopsy. Atrophy was 10%, intestinal metaplasia 16%, dysplasia 3.2%, Helicobacter pylori (HP) 36.6%, and malignancy was 1%. There was no significant difference according to gender in the morphological distribution of lesions (Table-8). In histological evaluation of gastric lesions; considering the morphological distribution by age group; the incidence of atrophy, intestinal metaplasia, and dysplasia were higher over 50, and there was a difference. Atrophy 4.1% vs. 13.5% (p=0.001), intestinal metaplasia 5.3% vs. 22.3% (p&lt;0.001), dysplasia 0.6% vs. 4.7% p=0.012 (Table-9).</p>
    <table-wrap id="tbl-2" position="float">
     <label>Table 2</label>
     <caption>
      <title>Distribution of anatomical locations of lesions detected in EGD by age group</title>
     </caption>
     <graphic xlink:href="tbl-2.png">
      <alt-text>Table 2: Distribution of anatomical locations of lesions detected in EGD by age group</alt-text>
     </graphic>
    </table-wrap>
   </sec>
   <sec id="sec-12">
    <title>Features of Duodenal Lesions</title>
    <p id="b-11">In the distribution of duodenal lesions by gender, the lesions seen in the bulbous were more common in males and were found to be statistically significant (p=0.002) (Table-10). No difference was found in the distribution of duodenal lesions by age group (Table-11).</p>
    <table-wrap id="tbl-3" position="float">
     <label>Table 3</label>
     <caption>
      <title>Distribution of anatomical locations of lesions detected in EGD by gender</title>
     </caption>
     <graphic xlink:href="tbl-3.png">
      <alt-text>Table 3: Distribution of anatomical locations of lesions detected in EGD by gender</alt-text>
     </graphic>
    </table-wrap>
    <table-wrap id="tbl-4" position="float">
     <label>Table 4</label>
     <caption>
      <title>Distribution of esophageal lesions by gender</title>
     </caption>
     <graphic xlink:href="tbl-4.png">
      <alt-text>Table 4: Distribution of esophageal lesions by gender</alt-text>
     </graphic>
    </table-wrap>
    <table-wrap id="tbl-5" position="float">
     <label>Table 5</label>
     <caption>
      <title>Distribution of esophageal lesions by age</title>
     </caption>
     <graphic xlink:href="tbl-5.png">
      <alt-text>Table 5: Distribution of esophageal lesions by age</alt-text>
     </graphic>
    </table-wrap>
    <table-wrap id="tbl-6" position="float">
     <label>Table 6</label>
     <caption>
      <title>Endoscopic classification of gastric lesions and distribution by gender</title>
     </caption>
     <graphic xlink:href="tbl-6.png">
      <alt-text>Table 6: Endoscopic classification of gastric lesions and distribution by gender</alt-text>
     </graphic>
    </table-wrap>
   </sec>
  </sec>
  <sec id="sec-13">
   <title>Discussion</title>
   <p id="b-12">EGD is an interventional procedure used in the diagnosis of esophageal, stomach, and duodenal diseases. It is generally accepted that many symptoms thought to be due to various benign and malignant upper gastrointestinal diseases are best evaluated by EGD. In this study, the EGD results of 500 patients in 2017 were retrospectively analyzed. 60% of the cases were female and 40% were male, and the mean age of females was 54.9±17.7 years, and the mean age of males was 53.9±17.9 years. Only 18 (3.6%) of 500 patients included in the study were found to be normal. Of the cases, 111 (22.2%) had esophageal disease, 474 (94.8%) gastric disease, 109 (21.8%) duodenal disease. These rates are 31.51% for esophageal diseases, 61.15% for gastric diseases, and 31.51% for duodenum in the Trakya University series; In the Dicle University series, 16.6% were found for esophageal diseases, 35.16% for gastric diseases, and 48.17% for duodenum. Gastric diseases were found to be more common in our study compared to other studies.</p>
   <table-wrap id="tbl-7" position="float">
    <label>Table 7</label>
    <caption>
     <title>Endoscopic classification of gastric lesions and distribution by age group</title>
    </caption>
    <graphic xlink:href="tbl-7.png">
     <alt-text>Table 7: Endoscopic classification of gastric lesions and distribution by age group</alt-text>
    </graphic>
   </table-wrap>
   <p id="b-13">Esophagitis in 47 (9.4%) of the cases included in the study, laxity of LES in 33 (6.6%), esophageal varices in 19 (3.8%), and hiatal hernia in 18 (3.6%). Esophagitis was the most common lesion among the esophageal lesions, and laxity of LES was the second most common lesion. The incidence of esophagitis is reported between 1.23-9.4% in the literature, and it was found to be at the upper limit with 9.4% in our study (    <xref ref-type="bibr" rid="ref1">1</xref>
,    <xref ref-type="bibr" rid="ref2">2</xref>
). Gastroesophageal reflux disease (GERD) is the most common disease of the esophagus, and the most common cause of esophagitis is reflux esophagitis. Considering that esophagitis was seen in 9.4% of our cases, it turns out that GERD is a very common entity in our region. In the analysis of esophageal lesions according to age groups; The incidence of hiatal hernia and esophageal varices was found to be higher over the age of 50. (Hiatal hernia 0.6% vs 5.3% p=0.006, Esophageal varices 1.1% vs 5.3% p=0.019). The fact that Hiatal hernias are generally seen after the age of 50 suggests the wear of the structures that make up the hiatus (    <xref ref-type="bibr" rid="ref3">3</xref>
). When cirrhosis is diagnosed; approximately 40% of those with compensated disease and approximately 60% of those with the decompensated disease have esophageal varices (    <xref ref-type="bibr" rid="ref4">4</xref>
,    <xref ref-type="bibr" rid="ref5">5</xref>
). The fact that esophageal varices are generally seen after the age of 50 in our study suggests that the development of varicose veins in cirrhosis is due to the complication that occurs over time after diagnosis. In our study; gastric lesions are the most common among all cases, and gastritis is the most common disease among all gastric diseases and endoscopy cases. In our country, gastritis was found to be 78% in the study conducted at Zonguldak Karaelmas University and 23% in the study conducted at Osmangazi University (    <xref ref-type="bibr" rid="ref6">6</xref>
,    <xref ref-type="bibr" rid="ref7">7</xref>
). In a study published in 2012 and conducted in Cuba, the rate of gastritis was reported as 91.6% (    <xref ref-type="bibr" rid="ref8">8</xref>
). In our study, we found gastritis at a rate of 93.4%. Nutritional habits, environmental factors, and genetic differences of the relevant regions may play a role in the serious differences in gastritis rates according to cities. We think that the high rate determined in our study is because there is more than one health institution in our region, which is easier to reach the city center. Since it is relatively more difficult to reach our hospital compared to other health institutions, patients who have more serious and persistent complaints or who are considered for the endoscopic procedure after evaluating risk factors are often referred to us by a physician. We think that this may explain the high rate of gastritis in patients undergoing endoscopy in our hospital. The classification of gastritis according to the Sydney system; is aimed to give combined topographic, morphological, and etiological information as a schema (    <xref ref-type="bibr" rid="ref9">9</xref>
). The most important feature of this system is the grading of changes in the gastric mucosa into five main histological features (chronic inflammation, neutrophil activity, glandular atrophy, intestinal metaplasia, and HP density) (    <xref ref-type="bibr" rid="ref10">10</xref>
). In our study, we classified gastritis according to the Sydney system. Considering the endoscopic topographic distribution of gastritis according to this classification; in line with the literature, pangastritis is the most common with 74.6%, and antral lesions are seen in the second line with 18.2%. Consistent with our study, in the endoscopic topographic distribution of the study conducted in Bayburt province, pangastritis is the most common with 74.6%, and antral lesions are seen in the second line with 18.2%. When the chronicity distribution of gastritis is considered, chronic lesions are more common with 63.2%, and there is no statistically significant difference according to gender and age group (p=0.552 by gender, p=0.06 by age). Peptic ulcer disease is most commonly localized in the bulbous of the duodenum. The second most common site is the prepyloric antrum. Duodenal ulcer is more common than a gastric ulcer. In our study, by the literature, when peptic ulcers were evaluated according to their anatomical regions; the incidence of gastric ulcer was 5.2%, the incidence of the duodenal ulcer was 8.6% (2.8% of ulcers in the bulbous, 5.8% of the second part of the duodenum). A duodenal ulcer was observed more frequently than a gastric ulcer. We think that the socioeconomic level of the region, stress, inappropriate use of antibiotics and nonsteroidal anti-inflammatory drugs (NSAIDs), and excessive consumption of animal food are effective in gastritis and ulcer formation. In our study, malignancy incidence in gastric lesions was 0.5% in males, 1.3% in females, and 1% in total. In a study conducted in the Netherlands, the rate of gastric cancer was found to be 1.1%, 1.75% in Vakıf Gureba University, 6.5% in Erzurum, 2.1% in Diyarbakır, and 1.99% in Düzce in our country (    <xref ref-type="bibr" rid="ref11">11</xref>
–    <xref ref-type="bibr" rid="ref14">14</xref>
). In the 2008 data of the Turkish Ministry of Health, gastric cancer rates in females in 2006-2008 were 7.6%, 8.4%, and 8%, respectively. In our study, cancer cases were found to be lower than the ministry rates. We think that diet, regional characteristics (climate, lifestyle, etc.), lifestyle are effective in carcinogenesis. In the histological evaluation of gastric lesions; when the morphological distribution is examined, inflammation is observed in all patients (281 females, 170 males, total of 451 patients) who underwent biopsy. HP 36.6%, atrophy 10%, intestinal metaplasia 16%, dysplasia 3.2%, malignancy 1% seen as. The prevalence of HP is 10-50% in developed countries and rises to 80% in developing countries. In the study published in Japan in 2017 on the frequency of HP, the prevalence of gastric HP was found to be 6.1% (    <xref ref-type="bibr" rid="ref15">15</xref>
). In a study published in our country in 2016 and conducted in Southeastern Anatolia, HP was detected in 84 (65%) of 129 patients with gastrointestinal complaints (    <xref ref-type="bibr" rid="ref16">16</xref>
). The fact that the frequency of HP did not differ according to age in our study suggests that the infection was acquired at young ages, the insufficiency of treatment, and the frequency of reinfection. Intestinal metaplasia (IM) is accepted as a precursor to malignancy. While intestinal metaplasia was 16% in our study, this rate was found to be 11-48% according to the literature (    <xref ref-type="bibr" rid="ref17">17</xref>
). The variation in the rates of IM within the country suggests the dietary habits at the forefront. In addition, it should be kept in mind socioeconomic and geographical conditions are also important. In the histological evaluation of gastric lesion; considering the morphological distribution by age group; the incidence of atrophy, intestinal metaplasia, and dysplasia are higher over the age of 50, and there is a statistically significant difference. This situation makes us think that the lesions leading to malignancy increase with age, and that nutritional habits and environmental factors may be effective in this situation. The incidence of ulcers in the duodenum in the cases included in our study was 8.6%, and it was 14.8% in 5306 patients in Vakıf Gureba University Internal Medicine Endoscopy Unit in our country, 1.6% in Şanlıurfa region, and 13.4% in Erzurum region (    <xref ref-type="bibr" rid="ref18">18</xref>
,    <xref ref-type="bibr" rid="ref19">19</xref>
). While the male/female ratio in duodenal ulcers was 5/1 in previous years, this ratio has decreased to 1.3/1 in recent years (    <xref ref-type="bibr" rid="ref20">20</xref>
). In our study, this ratio was found to be 1.5/1. Our study has some limitations such as the retrospective nature, relatively the high rate of the female population applying to the outpatient clinics, and regarding the only one year period in 2017. In addition, patients under the age of 18 who were not admitted to our outpatient clinics due to their age and the lower GI endoscopy such as rectoscope, recto sigmoidoscopy, and total colonoscopy findings and biopsy results were not included.</p>
   <table-wrap id="tbl-8" position="float">
    <label>Table 8</label>
    <caption>
     <title>Morphological classification of gastric lesions and distribution by gender</title>
    </caption>
    <graphic xlink:href="tbl-8.png">
     <alt-text>Table 8: Morphological classification of gastric lesions and distribution by gender</alt-text>
    </graphic>
   </table-wrap>
   <table-wrap id="tbl-9" position="float">
    <label>Table 9</label>
    <caption>
     <title>Morphological classification of gastric lesions and distribution by age group</title>
    </caption>
    <graphic xlink:href="tbl-9.png">
     <alt-text>Table 9: Morphological classification of gastric lesions and distribution by age group</alt-text>
    </graphic>
   </table-wrap>
  </sec>
  <sec id="sec-14">
   <title>Conclusion</title>
   <p id="b-14">Only 18 (3.6%) of 500 patients were normal. 111 (22.2%) had esophageal, 474 (94.8%) gastric, 109 (21.8%) duodenal disease. Gastritis was the most common disease among both gastric diseases and all cases undergoing endoscopy. Also, HP was seen in 165 (36.6%) of all cases. By analyzing the endoscopic lesions that are frequently seen within a year in our region via our study, we may predict that diagnostic evaluation of signs and symptoms of a wide variety of GIS disorders should be performed. Considering our study and various studies, upper GI endoscopy is generally a safe procedure for this purpose in patients presenting with various GIS complaints (21-24). Despite the rising prevalence of EGD, annual reports in the diagnostic evaluation of signs and symptoms of a wide variety of GI disorders and current related studies on this subject are very limited in our country. Hereby, we believe that our study may lead to further studies being planned in the future.</p>
   <table-wrap id="tbl-10" position="float">
    <label>Table 10</label>
    <caption>
     <title>Classification of duodenal lesions and distribution by gender</title>
    </caption>
    <graphic xlink:href="tbl-10.png">
     <alt-text>Table 10: Classification of duodenal lesions and distribution by gender</alt-text>
    </graphic>
   </table-wrap>
   <table-wrap id="tbl-11" position="float">
    <label>Table 11</label>
    <caption>
     <title>Classification of duodenal lesions and distribution by age group</title>
    </caption>
    <graphic xlink:href="tbl-11.png">
     <alt-text>Table 11: Classification of duodenal lesions and distribution by age group</alt-text>
    </graphic>
   </table-wrap>
  </sec>
 </body>
 <back>
  <ref-list>
   <title>References</title>
   <ref id="ref1">
    <label>1</label>
    <mixed-citation publication-type="journal">Alper. A., Dağalp K., Karaeren N. et al. Comparison of Upper Gastrointestinal System Endoscopy Results performed in GATA Gastroenterology Clinic with SSK Patients. National Turkish Gastroenterology Congress, 1993;347</mixed-citation>
   </ref>
   <ref id="ref2">
    <label>2</label>
    <mixed-citation publication-type="journal">Aksöz MK., Altınay ZA., Ünsal B. et al. Evaluation of 3176 Upper Gastrointestinal Endoscopic Examinations. Gastro enterology. 1993;4:668-70</mixed-citation>
   </ref>
   <ref id="ref3">
    <label>3</label>
    <mixed-citation publication-type="journal">Skinner DB, Ellis FH, Lovv DE, Hill LD, Orringer MB. Esophageal Hiatal Hernia, In: Gibbon's Surgery of the Chest, Eds: Sabiston DC, Spencer FC, Fourth Edition, W. B. Saunders Company, Philadelphia, USA, 1990:890-956</mixed-citation>
   </ref>
   <ref id="ref4">
    <label>4</label>
    <mixed-citation publication-type="journal">Goyal RK. Diseases of the Esophagus In Harrison's Principles of Internal Edition: Fauci SA, Braunwald £, Isselbacher K, et al. 15th Ed. McGraw-Hill Inc. International Edition, 2002. A. Kadayıfçı. UTS- Experts Tus Series, Internal Medicine, Atlas Publishing, 2003, 4th edition, Ankara</mixed-citation>
   </ref>
   <ref id="ref5">
    <label>5</label>
    <mixed-citation publication-type="journal">Irkörücü O, Gültekin F.A., Uçan B.H. et al. Endoscopic Diagnosis and Pathological Diagnosis Compatibility in Esophagogastroscopy performed by General Surgeons-Original Research. Haseki Medical Bulletin 2011;49(3): 26-39</mixed-citation>
   </ref>
   <ref id="ref6">
    <label>6</label>
    <mixed-citation publication-type="journal">Sarıçam T, Aladağ A, Şahintürk V, et al. Upper Gastrointestinal System Endoscopic Findings and Helicobacter Pylori Infection. Journal of Endoscopy 1993; 4:209-214</mixed-citation>
   </ref>
   <ref id="ref7">
    <label>7</label>
    <mixed-citation publication-type="journal">Galban E, Arus E, Periles U. Endoscopic Findings and Associated Risk Factors in Primary Health Care Settings in Havana, Cuba. MEDICC Review 2012;14:30-37</mixed-citation>
   </ref>
   <ref id="ref8">
    <label>8</label>
    <mixed-citation publication-type="journal">Dixon MF, Genta RM, Yardley JH, Correa P, et al. Classification and grading of gastritis The updated Sydney system. Am J Surg Pathol 1996;20:1161–81</mixed-citation>
   </ref>
   <ref id="ref9">
    <label>9</label>
    <mixed-citation publication-type="journal">Price AB. The Sydney System: Histological division. J Gastroenterol Hepatol 1991;6:209– 22</mixed-citation>
   </ref>
   <ref id="ref10">
    <label>10</label>
    <mixed-citation publication-type="journal">Castell DO, Donner MW. Evaluation of dysphagia: a careful history is crucial. Dysphagia 1987;2:65</mixed-citation>
   </ref>
   <ref id="ref11">
    <label>11</label>
    <mixed-citation publication-type="journal">Mulhall BP, Wong RK. Infectious esophagitis. Curr Treat Options Gastroenterol 2003;6:55-70</mixed-citation>
   </ref>
   <ref id="ref12">
    <label>12</label>
    <mixed-citation publication-type="journal">Mellow M. Symptomatic diffuse esophageal spasm mano metric follow-up and response to cholinergic stimulation and cholinesterase inhibition. Gastroenterology 1977; 73:237</mixed-citation>
   </ref>
   <ref id="ref13">
    <label>13</label>
    <mixed-citation publication-type="journal">Chuong JJ, DuBovifc SY, McCallum RW. Achalasia as a risk factor for esophageal carcinoma: a reappraisal. Dig Dis Sei 1984;29:1105</mixed-citation>
   </ref>
   <ref id="ref14">
    <label>14</label>
    <mixed-citation publication-type="journal">Republic of Türkiye Ministry of Health 2010 Statistics Data.</mixed-citation>
   </ref>
   <ref id="ref15">
    <label>15</label>
    <mixed-citation publication-type="journal">Overby A, Murayama SY, Michimae H, Suzuki H, Suzuki M, Serizawa H, et al. Prevalence of Gastric Non-Helicobacter pylori-Helicobacters in Japanese Patients with Gastric Disease. Digestion 2017;95(1):61–66</mixed-citation>
   </ref>
   <ref id="ref16">
    <label>16</label>
    <mixed-citation publication-type="journal">Rugge M, Di Mario F, Cassaro M, et al: Pathology of the gastric antrum and body associated with Helicobacter pylori infection in non-ulcer patients: is the bacterium a promoter of intestinal metaplasia? Histopathology 1993; 22:9-15</mixed-citation>
   </ref>
   <ref id="ref17">
    <label>17</label>
    <mixed-citation publication-type="journal">Meijssen MA, Tilanus HW, van Blankenstein M, Hop WC, Ong GL. Achalasia complicated by oesophageal squamous cell carcinoma: a prospective study in 195 patients. Gut 1992;33: 155</mixed-citation>
   </ref>
   <ref id="ref18">
    <label>18</label>
    <mixed-citation publication-type="journal">Qualman SJ, Haupt HM, Yang P, Hamilton SR. Esophageal Lewy bodies associated with ganglion cell loss in Achalasia. Similarity to Parkinson’s disease. Gastro enterology 1984;87: 848</mixed-citation>
   </ref>
   <ref id="ref19">
    <label>19</label>
    <mixed-citation publication-type="journal">Chan FKL, Leung WK. Peptic Ulcer Disease. Lancet 2002; 360: 933-41</mixed-citation>
   </ref>
   <ref id="ref20">
    <label>20</label>
    <mixed-citation publication-type="journal">Fennerty MB., complications of endoscopy. In: Clinical practice of gastroenterology. Brandt LJ (ed). Volume 2. Current medicine. 1999:1539-1548</mixed-citation>
   </ref>
   <ref id="ref21">
    <label>21</label>
    <mixed-citation publication-type="journal">Silvis SE., Nebel O., Rogers G., Sugawa C., Mandelstam P. Endoscopic complications. Result of the 1974 American Society for Gastrointestinal Endoscopy Survey. JAMA. 1976; 235(9):928-930 29 77 Esophagogastroduodenoscopy Applications Bulunmaz et al.</mixed-citation>
   </ref>
   <ref id="ref22">
    <label>22</label>
    <mixed-citation publication-type="journal">Mousavi S., Nobahar M., Vafaei A.A., Malek M., Babaei M., Malek F., et al. Complications of upper gastrointestinal endoscopy in unsedated patients. Indian J. Gastroenterol. 2004;23(5):193</mixed-citation>
   </ref>
   <ref id="ref23">
    <label>23</label>
    <mixed-citation publication-type="journal">Wolfsen HC, Hemminger LL, Achem SR, Loeb DS, Stark ME, Bouras EP., et al. Complications of endoscopy of the upper gastrointestinal tract: a single-centre experience. Mayo Clin proc. 2004;79(10):1264-1267</mixed-citation>
   </ref>
  </ref-list>
 </back>
</article>
